REGENXBIO Inc. Quarterly Marketable Securities, Current in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
REGENXBIO Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2015 to Q2 2024.
  • REGENXBIO Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $233M, a 7.51% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $233M -$18.9M -7.51% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $226M -$36M -13.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $241M -$27M -10.1% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $249M -$15M -5.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $251M -$30.1M -10.7% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $262M +$59.5M +29.4% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $268M +$155M +139% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $264M +$152M +137% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $282M +$164M +139% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $202M +$52.9M +35.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $112M -$25.1M -18.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $111M -$36.8M -24.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $118M -$57.3M -32.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $149M -$60.4M -28.8% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $137M -$89.4M -39.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $148M -$104M -41.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $175M -$111M -38.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $210M -$19.5M -8.51% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $227M -$17.5M -7.17% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $252M +$22M +9.54% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $286M +$107M +59.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $229M +$71.4M +45.2% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $244M +$130M +114% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $230M +$123M +116% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $180M +$75.2M +72% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $158M +$94.2M +148% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $114M +$49.4M +76.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $107M +$43.1M +67.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $104M +$40.3M +62.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $63.8M -$1.78M -2.72% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $64.7M +$4.69M +7.81% Dec 31, 2016 10-K 2018-03-06
Q3 2016 $63.7M +$55.6M +693% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $64.1M Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $65.5M Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $60M Dec 31, 2015 10-K 2017-03-07
Q3 2015 $8.03M Sep 30, 2015 10-Q 2015-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.